HopeStage
Back to all studies
Enrolling By InvitationNCT07405463

Effects of tDCS on Fear Reversal in Patients With Anxiety Disorders

Device studyAges 18–65China
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
GuangzhouSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: December 1, 2025
Recruitment status
Enrolling By Invitation
Enrollment listed in the registry
140
Sponsor
Jingchu Hu
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device
Locations
China
Age range
From 18 Years to 65 Years
Official registry ID
NCT07405463
Official title
Show the full official title

A Randomized, Double-Blind, Controlled Study of Transcranial Direct Current Stimulation Intervention on Fear Reversal in Patients With Anxiety Disorders

Recruitment & locations

By invitation

Guangzhou

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Jingchu Hu.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as enrolling by invitation.

Want to explore more studies?

Explore studies